Principal Financial Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $5.92K | Hold |
|
|||||
|
2024
Q4 | $7.04K | Sell |
|
|||||
|
2024
Q3 | $15.5K | Sell |
|
|||||
|
2024
Q2 | $38.4K | Sell |
|
|||||
|
2024
Q1 | $130K | Sell |
|
|||||
|
2023
Q4 | $122K | Sell |
|
|||||
|
2023
Q3 | $100K | Buy |
|
|||||
|
2023
Q2 | $191K | Buy |
|
|||||
|
2023
Q1 | $129K | Buy |
|
|||||
|
2022
Q4 | $170K | Buy |
|
|||||
|
2022
Q3 | $335K | Buy |
|
|||||
|
2022
Q2 | $235K | Sell |
|
|||||
|
2022
Q1 | $241K | Buy |
|
|||||
|
2021
Q4 | $222K | Buy |
|